John C. Messinger
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 6
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 2
-
- Substance Abuse Treatment and Outcomes 3
- Co-authors
- Navin K. Chintala (6 shared papers)Prasad S. Adusumilli (6 shared papers)Zachary E. Tano (3 shared papers)Claudia Diamonte (3 shared papers)David R. Jones (3 shared papers)Shanu Modi (3 shared papers)Isabelle Rivière (3 shared papers)Stephen B. Solomon (3 shared papers)
- Journals
- Journal of Addiction Medicine (2 papers)Journal of Clinical Oncology (1 paper)Clinical Trials (1 paper)Neuropsychopharmacology (1 paper)Cell Reports Methods (1 paper)
- Partner nations
- United StatesColombia
In The Last Decade
John C. Messinger
16 papers receiving 248 citations
Peers
Comparison fields: 5 of 48
- Oncology 174
- Immunology 59
- Genetics 50
- Biotechnology 15
- Biomedical Engineering 59
Countries citing papers authored by John C. Messinger
This map shows the geographic impact of John C. Messinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Messinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Messinger more than expected).
Fields of papers citing papers by John C. Messinger
This network shows the impact of papers produced by John C. Messinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Messinger. The network helps show where John C. Messinger may publish in the future.
Co-authors
The 25 scholars most cited alongside John C. Messinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 79 | |
| 2 | 2019 | 76 | |
| 3 | 2019 | 45 | |
| 4 | 2023 | 14 | |
| 5 | 2019 | 8 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 4 | |
| 8 | 1973 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 3 | |
| 11 | 2018 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2022 | 1 | |
| 16 | 2023 | 1 |
About John C. Messinger
John C. Messinger is a scholar working on Oncology, Epidemiology, Public Health, Environmental and Occupational Health, Neurology and Cognitive Neuroscience, having authored 16 papers that have together received 254 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Opioid Use Disorder Treatment (4 papers), Substance Abuse Treatment and Outcomes (3 papers), Neural and Behavioral Psychology Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Healthcare Decision-Making and Restraints (1 paper) and Behavioral Health and Interventions (1 paper). The work is most often cited by research in Oncology (174 citations), Immunology (59 citations), Genetics (50 citations), Biotechnology (15 citations) and Biomedical Engineering (59 citations). John C. Messinger has collaborated with scholars based in United States and Colombia. Frequent co-authors include Navin K. Chintala, Prasad S. Adusumilli, Zachary E. Tano, Claudia Diamonte, David R. Jones, Shanu Modi, Isabelle Rivière, Stephen B. Solomon, Valerie W. Rusch and Marjorie G. Zauderer. Their work appears in journals such as Journal of Addiction Medicine, Journal of Clinical Oncology, Clinical Trials, Neuropsychopharmacology and Cell Reports Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.